Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients.

By S. Ganesh, A. Stack, N. Levin, T. Hulbert-Shearon, F. Port. Journal of the American Society of Nephrology, 2001

1,253 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. (2007, unknown): “13 Current smokers (n % ) 18 (16) 16 (25) 0.”
Activated injectable vitamin D and hemodialysis survival: a historical cohort study. (2005, result): “Nevertheless, previous observational studies implicating alterations of serum calcium, phosphorus, or PTH as independent factors associated with mortality among chronic hemodialysis patients did not often account for whether patients were receiving injectable vitamin D, and whether vitamin D adminis”
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) (2009, unknown): “Lindberg129 395 (294) 6 mo Hamdy 40 176 (89) 24 mo Finn109 1359 (682) 24 mo Qunibi99 203 (103) 12 mo”